These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9740601)

  • 1. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.
    Hunt SC; Cook NR; Oberman A; Cutler JA; Hennekens CH; Allender PS; Walker WG; Whelton PK; Williams RR
    Hypertension; 1998 Sep; 32(3):393-401. PubMed ID: 9740601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
    Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene.
    Hunt SC; Geleijnse JM; Wu LL; Witteman JC; Williams RR; Grobbee DE
    Am J Hypertens; 1999 May; 12(5):460-6. PubMed ID: 10342783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensinogen genotype and blood pressure responses to reduced dietary NaCl and to weight loss.
    Kotchen TA
    Hypertension; 1998 Sep; 32(3):402-3. PubMed ID: 9740602
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.
    He J; Whelton PK; Appel LJ; Charleston J; Klag MJ
    Hypertension; 2000 Feb; 35(2):544-9. PubMed ID: 10679495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure is linked to salt intake and modulated by the angiotensinogen gene in normotensive and hypertensive elderly subjects.
    Johnson AG; Nguyen TV; Davis D
    J Hypertens; 2001 Jun; 19(6):1053-60. PubMed ID: 11403353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group.
    Whelton PK; Kumanyika SK; Cook NR; Cutler JA; Borhani NO; Hennekens CH; Kuller LH; Langford H; Jones DW; Satterfield S; Lasser NL; Cohen JD
    Am J Clin Nutr; 1997 Feb; 65(2 Suppl):652S-660S. PubMed ID: 9022561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.
    Whelton PK; Appel LJ; Espeland MA; Applegate WB; Ettinger WH; Kostis JB; Kumanyika S; Lacy CR; Johnson KC; Folmar S; Cutler JA
    JAMA; 1998 Mar; 279(11):839-46. PubMed ID: 9515998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study.
    Svetkey LP; Moore TJ; Simons-Morton DG; Appel LJ; Bray GA; Sacks FM; Ard JD; Mortensen RM; Mitchell SR; Conlin PR; Kesari M;
    J Hypertens; 2001 Nov; 19(11):1949-56. PubMed ID: 11677359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of "angiotensin genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II".
    Schork NJ
    Curr Hypertens Rep; 1999; 1(1):13-4. PubMed ID: 10981037
    [No Abstract]   [Full Text] [Related]  

  • 11. Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Hebert PR; Bolt RJ; Borhani NO; Cook NR; Cohen JD; Cutler JA; Hollis JF; Kuller LH; Lasser NL; Oberman A
    Ann Epidemiol; 1995 Mar; 5(2):130-9. PubMed ID: 7795831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensinogen T174M and M235T variants, sodium intake and hypertension among non-drinking, lean Japanese men and women.
    Iso H; Harada S; Shimamoto T; Sato S; Kitamura A; Sankai T; Tanigawa T; Iida M; Komachi Y
    J Hypertens; 2000 Sep; 18(9):1197-206. PubMed ID: 10994750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A core promoter variant of angiotensinogen gene and interindividual variation in response to angiotensin-converting enzyme inhibitors.
    Yu H; Lin S; Zhong J; He M; Jin L; Zhang Y; Liu G
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):540-6. PubMed ID: 25143324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension.
    Giner V; Poch E; Bragulat E; Oriola J; González D; Coca A; De La Sierra A
    Hypertension; 2000 Jan; 35(1 Pt 2):512-7. PubMed ID: 10642351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension.
    Mondorf UF; Russ A; Wiesemann A; Herrero M; Oremek G; Lenz T
    Am J Hypertens; 1998 Feb; 11(2):174-83. PubMed ID: 9524045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between the variants in 5' upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang].
    Li NF; Zhou L; Wu WD; Shi Y; Wang XL; Wang J; Li HJ; Zhang DL; Zu H; Ouyang WJ; Bu KL; Zhou KM; Cheng QY; Guli N; Zhu DH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):23-8. PubMed ID: 14767903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I.
    JAMA; 1992 Mar; 267(9):1213-20. PubMed ID: 1586398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body weight changes and the A-6G polymorphism of the angiotensinogen gene.
    Chaves FJ; Giner V; Corella D; Pascual J; Marin P; Armengod ME; Redon J
    Int J Obes Relat Metab Disord; 2002 Sep; 26(9):1173-8. PubMed ID: 12187393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Lasser VI; Raczynski JM; Stevens VJ; Mattfeldt-Beman MK; Kumanyika S; Evans M; Danielson E; Dalcin A; Batey DM; Belden LK
    Ann Epidemiol; 1995 Mar; 5(2):156-64. PubMed ID: 7795834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation.
    Dodson PM; Beevers M; Hallworth R; Webberley MJ; Fletcher RF; Taylor KG
    BMJ; 1989 Jan; 298(6668):227-30. PubMed ID: 2493869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.